Atlas Trials

First-line Replacement Maintenance of Envafolimab in Advanced NSCLC

Clinical trial NCT05465733 · UNKNOWN

Trial details

NCT number
NCT05465733
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung
Start date
2022-08-01
Primary completion
2025-06-30
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.